Asnicar, Francesco
Università di Trento,
Italy
2025 Rank: 48,524
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 950 out of 217,955 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 48,524 | 51,222 |
| Total Cites | 6,257 | 6,563 |
| H-index | 24 | 24 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 11 | 11 |
| Total Cites to Single+First Authored Papers | 431 | 470 |
| Number of Single+First+Last Authored Papers | 12 | 12 |
| Total Cites to Single+First+Last Authored Papers | 438 | 477 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 5,664 | 5,784 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.13 |
| Self-Citation Percentage |
4.66%
|
|
Asnicar, Francesco
Università di Trento,
Italy
2024 Rank: 64,277
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Biomedical Research
SubField 1:
Microbiology
SubField 2:
Immunology
Rank in SubField 1: 1,329 out of 204,759 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 64,277 | 67,260 |
| Total Cites | 4,912 | 5,152 |
| H-index | 22 | 23 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 10 | 10 |
| Total Cites to Single+First Authored Papers | 362 | 394 |
| Number of Single+First+Last Authored Papers | 10 | 10 |
| Total Cites to Single+First+Last Authored Papers | 362 | 394 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 4,519 | 4,636 |
| Ratio of Total Citations to Distinct Citing Papers | 1.09 | 1.11 |
| Self-Citation Percentage |
4.66%
|
|
Asnicar, Francesco
Università di Trento,
Italy
2023 Rank: 65,326
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 1,467 out of 147,556 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 65,326 | 71,234 |
| Total Cites | 4,435 | 4,631 |
| H-index | 21 | 22 |
| Hm-index | 2 | 2 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 419 | 444 |
| Number of Single+First+Last Authored Papers | 9 | 9 |
| Total Cites to Single+First+Last Authored Papers | 419 | 444 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 4,050 | 4,168 |
| Ratio of Total Citations to Distinct Citing Papers | 1.10 | 1.11 |
| Self-Citation Percentage |
4.23%
|
|
Asnicar, Francesco
Università di Trento,
Italy
2022 Rank: 112,675
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Immunology
SubField 2:
Microbiology
Rank in SubField 1: 2,604 out of 138,599 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 112,675 | 119,651 |
| Total Cites | 2,897 | 3,101 |
| H-index | 18 | 19 |
| Hm-index | 1 | 1 |
| Number of Single Authored Papers | 0 | 0 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 9 | 9 |
| Total Cites to Single+First Authored Papers | 229 | 250 |
| Number of Single+First+Last Authored Papers | 9 | 9 |
| Total Cites to Single+First+Last Authored Papers | 229 | 250 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 2,689 | 2,811 |
| Ratio of Total Citations to Distinct Citing Papers | 1.08 | 1.10 |
| Self-Citation Percentage |
6.58%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.